Related Experiment Videos

[Expression of IL6 and TNF-alpha in normal and pathological kidney]

D Boucher1, J Gogusev, D Droz

  • 1Laboratoire de Pathologie Rénale, Hôpital Necker, Paris.

Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|January 1, 1993
PubMed

Insights

Kidney cells produce Interleukin-6 (IL6) and Tumor Necrosis Factor-alpha (TNF alpha) in various diseases. Their exact roles in kidney damage require further investigation.

Area of Science:

  • Nephrology
  • Immunology
  • Molecular Biology

Context:

  • Interleukin-6 (IL6) and Tumor Necrosis Factor-alpha (TNF alpha) are key cytokines involved in inflammation and cellular processes.
  • Their expression and role in normal and pathological kidney conditions have been areas of interest.

Purpose:

  • To investigate the expression and localization of IL6 and TNF alpha in normal human kidneys and in various renal pathologies, including glomerulonephritis, transplant rejection, and renal cell carcinoma.
  • To determine whether parenchymal renal cells can produce these cytokines under different pathological conditions.

Summary:

  • In normal kidneys, IL6 mRNA and protein are present in the glomerulus, while TNF alpha is absent.
  • Mesangioproliferative glomerulonephritis shows increased IL6 mRNA and protein in glomeruli, with TNF alpha localized to macrophages.
  • Acute renal transplant rejection involves de novo TNF alpha expression in tubular cells, alongside HLA class II, ICAM-1, and VCAM-1.
  • Renal cell carcinomas exhibit both IL6 and TNF alpha production by tumoral cells at mRNA and protein levels.
  • These findings indicate that renal parenchymal cells can produce IL6 and TNF alpha in various pathological states.

Impact:

  • This study highlights the differential expression of IL6 and TNF alpha in diverse renal diseases, suggesting their potential involvement in kidney pathophysiology.
  • It establishes that renal parenchymal cells are a source of these cytokines in pathological conditions.
  • Further research is needed to elucidate the regulatory mechanisms and precise roles of IL6 and TNF alpha in kidney damage and disease progression.

Related Concept Videos